##  [PKC412](/node/72756 "PKC412") 

  



Rydapt®

[In-market Brands and Global Health](/taxonomy/term/11046)

[Phase 2](/taxonomy/term/2881)

[2027](/taxonomy/term/2806)

[Multi-targeted kinase inhibitor](/taxonomy/term/4256)

 

Acute myeloid leukemia, pediatrics

[Supplementary Indication](/taxonomy/term/2791)



- [Print](/node/72756/printable/print)
- [PDF](/node/72756/printable/pdf)